Once-daily Fluorometholone vs Twice-daily Cyclosporine in Dry Eye Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

March 1, 2024

Study Completion Date

May 24, 2024

Conditions
Dry Eye Disease (DED)
Interventions
DRUG

Fluorometholone 0.1% ophthalmic solution

After induction therapy with fluorometholone 0.1% four times a day for 4 weeks, patients continued with fluorometholone 0.1% once a day for 8 weeks.

DRUG

Cyclosporine 0.05% eye drops

After induction therapy with fluorometholone 0.1% four times a day for 4 weeks, patients continued with cyclosporine 0.05% twice a day for 8 weeks.

Trial Locations (1)

02841

Korea University Anam Hospital, Seoul

All Listed Sponsors
collaborator

Taejoon Pharmaceutical Co., Ltd.

INDUSTRY

lead

Korea University Anam Hospital

OTHER